Hutch News

Hutch News

Stories tagged 'HIV Prevention'

WHO recommends daily HIV prevention pill for all men who have sex with men

But researchers caution daily adherence may not be realistic and are looking into alternatives

July 15, 2014 | By Dr. Rachel Tompa

World Health Organization recommends daily HIV prevention pill for all men who have sex with men.

View story >


CDC recommends daily pill for those at high risk for HIV

Researchers work on long-lasting injectable drug; vaccine still ‘the holy grail’

May 15, 2014 | By Mary Engel

View story >


Thai HIV vaccine trial follow-up studies offer possible explanation for HIV prevention success

Peter Gilbert and SCHARP researchers, HVTN Laboratory Program, part of worldwide effort to understand trial outcome, influence future HIV vaccine studies

April 9, 2012

Fred Hutchinson Cancer Research Center researchers played a key role in the discovery of important immune responses that may have protected some volunteers from HIV in the RV144 Thai trial, the first HIV vaccine trial to show modest effectiveness in preventing HIV infection. Results from extensive RV144 laboratory studies were published April 5 in the New England Journal of Medicine.

View story >


SCHARP played key role in scientific breakthrough of the year

Science magazine selected HIV prevention trial for its top honor of 2011; study showed early antiretroviral therapy reduced heterosexual HIV transmission by 96 percent

Jan. 9, 2012 | By Colleen Steelquist and Dean Forbes

The Hutchinson Center's Statistical Center for HIV/AIDS Research & Prevention (SCHARP) played a key role in the HIV prevention study that Science magazine recently chose as its scientific breakthrough of the year for 2011.

View story >


Circumcision for HIV prevention

Citing a new study from Uganda, Dr. Judith Wasserheit's New England Journal of Medicine editorial concludes 'circumcision offers an important prevention opportunity and should be widely available'

March 30, 2009

According to an editorial by Dr. Judith Wasserheit, of the Fred Hutchinson Cancer Research center Clinical Research Division and the Vaccine and Infectious Disease Institute, co-authored by Dr. Matthew Golden of the University of Washington Center for AIDS and STD and the Seattle-King County Public Health Department’s STD Control Program, circumcision of adult and newborn males is an important tool for preventing HIV and other sexually-transmitted diseases and should be made widely available in areas of high disease prevalence around the world, according to a recent editorial in last week’s New England Journal of Medicine.

View story >


Center researchers celebrate microbicide milestone

Vaginal gel holds potential as a female-controlled method of HIV prevention

March 16, 2009

A clinical trial involving more than 3,000 women in seven sites (six in Africa; one in the United States) has demonstrated for the first time that a vaginal microbicide gel may prevent male-to-female sexual transmission of HIV infection. The study investigators, including Drs. Benoit Masse and Barbra Richardson, statisticians in the Fred Hutchinson Cancer Research Center's Vaccine and Infectious Disease Institute, presented the findings at the recent Conference on Retroviruses and Opportunistic Infections in Montreal.

View story >



GIVE NOW &
SAVE LIVES

Support our quest for cures

Story Archive


Publications

Hutch Magazine
Our quarterly magazine

Annual Report
Fiscal year highlights

Science Spotlight
Monthly review of Center-authored papers



Fred Hutch News

        Get updates via email.